Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7465790 Therapeutic antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 9, 2001
Date of Patent
December 16, 2008
Patent Application Number
09979948
Patent Citations Received
‌
US Patent 12091442 Activatable cytokine constructs and related compositions and methods
0
‌
US Patent 11945874 Anti-human CD52 immunoglobulins
0
‌
US Patent 11992528 Compositions and methods for conjugating activatable antibodies
0
‌
US Patent 11753466 Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
‌
US Patent 11802158 Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same
‌
US Patent 11859010 Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
0
‌
US Patent 11867695 Compositions and methods for detecting protease activity in biological systems
0
‌
US Patent 11884746 Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
0
‌
US Patent 11890354 Activatable antibodies that bind epidermal growth factor receptor and methods thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7465790
Patent Primary Examiner
‌
Larry R. Helms

Find more entities like US Patent 7465790 Therapeutic antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo